Incyte's average Accounts Payable for the
three
months ended in Jun. 2022 was $174 Mil. Incyte's Cost of Goods Sold for the
three
months ended in Jun. 2022 was $51 Mil.
Hence, Incyte's Days Payable for the
three
months ended in Jun. 2022 was 313.17.
The historical rank and industry rank for Incyte's Days Payable or its related term are showing as below:
INCY'
s Days Payable Range Over the Past 10 Years
Min: 253.55 Med: 332 Max: 33593.95
Current: 311.81
During the past 13 years, Incyte's highest Days Payable was 33593.95. The lowest was 253.55. And the median was 332.00.
INCY's Days Payable is ranked better than 70.21% of 678
companies
in the Biotechnology industry
Industry Median: 130.14
vs INCY: 311.81
Incyte's Days Payable
increased
from Jun. 2021 (248.73) to Jun. 2022 (313.17).
It may suggest that Incyte delayed paying its suppliers.
Incyte Days Payable Historical Data
The historical data trend for Incyte's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Incyte Annual Data
Trend
Dec12
Dec13
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Days Payable
328.98
332.53
299.47
253.55
327.38
Incyte Quarterly Data
Sep17
Dec17
Mar18
Jun18
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Days Payable
248.73
270.56
297.88
347.71
313.17
Competitive Comparison
For the Biotechnology subindustry, Incyte's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Incyte Days Payable Distribution
For the Biotechnology industry and Healthcare sector, Incyte's Days Payable distribution charts can be found below:
* The bar in red indicates where Incyte's Days Payable falls into.
Incyte Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Incyte's Days Payable for the fiscal year that ended in Dec. 2021 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Incyte Days Payable Related Terms
Thank you for viewing the detailed overview of Incyte's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.
Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis. Incyte's pipeline includes a broad array of oncology and dermatology programs.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
2.19(3.29%) Volume: 1,364,693 4:00PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NAS:INCY has been successfully added to your 
